Gut microbiome analysis firm DayTwo will collaborate with Johnson & Johnson on personalised clinical nutrition for diabetes, and plans to open up its nutrition recommendation platform to new partners.
Health Canada has received over 3,500 written comments in response to its proposed changes to how natural health products and dietary supplements are regulated.
A combination of strawberry and cranberry polyphenols may improve insulin sensitivity in overweight and non-diabetic, insulin-resistant adults, according to a new study.
Supplements formulated with Sabinsa’s Curcumin C3 Complex and BioPerine may reduce oxidative stress in patients suffering from type 2 diabetes, according to results of a randomized controlled trial.
Around 70% of consumers around the globe (60% of Americans) said they actively make dietary choices to help prevent health conditions, such as obesity, diabetes, and high cholesterol, according to a Nielsen report published last September.
Fibre supplementation helped to boost weight loss and lower blood sugar in overweight and obese adults, according to a new Australian study.
Diabetes is the seventh leading cause of death in the United States, and accounts for around $245 billion in medical costs and lost productivity each year, according to data from The State of Obesity, which drew information from CDC's Behavioral Risk Factor Surveillance System, encompassing telephone interviews with more than 400,000 Americans each year.
Galcatomannan from seeds of Brazilian ironwood (Caesalpinia ferrea), when administered at doses of 10 mg/kg body weight to Wistar rats with induced diabetes, was effective to control hyperglycemia and to promote recovering of insulin sensitivity in adipose tissue, researchers found.
From immune support to deep dives into sports nutrition, personalized nutrition, botanicals, omega-3s, probiotics, pet supplements, and more, Nutraingredients-USA’s 2016 editorial calendar of special editions spans the hottest trends in the industry.
Researchers found that the supplemented mice experienced changes in their gut microbiota that “may contribute to resveratrol’s anti-diabetic effects.”
Trust is a fickle thing. Just ask the political candidates in the recent election. It’s built over time and can be squandered overnight.
After comparing 10 different articles that looked at fenugreek’s effects on hyperglycemia and hyperlipidemia, researchers at the Huazhong University of Science and Technology in China found that fenugreek has some hypoglycemic and total cholesterol-lowering benefits.
Supplementation with ginseng berry extract could significantly decrease serum concentration of fasting glucose and postprandial glucose at 60 minutes in those with impaired glucose levels, compared to placebo.
Omega-3s, fiber, antioxidants, clean label, non-GMO, gluten-free, and plant-based: Chia ticks many of the hot button boxes for 21st Century consumers, so it is perhaps unsurprising that it is turning up in more new products than any other ancient grain.
A patented L-citrulline/L-arginine ingredient is more effective in boosting plasma L-arginine levels than the individual amino acids alone, says a new study.
Ingredients giant BASF will collaborate with Irish start-up Nuritas on the discovery and commercialisation of novel functional peptides using DNA analysis and artificial intelligence (AI).
Blueberries may regulate glucose, lipid metabolism, and improvement of inflammation, according to evidence discovered by Australian researchers from Victoria University in a new review.
Daily supplements containing rose hip powder may prevent weight gain in lab mice, compared to mice eating a high fat diet only, says a new study from Sweden.
Blue maize antioxidants may help protect against metabolic syndrome, cardiovascular disease and diabetes raising possibilities of using blue maize as a nutraceutical and functional food component.
Creating and disseminating analytic tools for biomarkers, seeking to better understand the microbiome, and enhancing consumer to the Dietary Supplement Label Database are just some of the new directions outlined by the Office of Dietary Supplements for 2017-2021.
The FDA recently authorized a level C qualified health claim for high-amylose maize resistant starch and a reduced risk of type 2 diab...
Diabetes and the associated costs of controlling the disease cast a long shadow over the US market. According to the World Health Org...